Policy / Regulatory

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented
GQCE testing

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

China's National Medical Products Administration (NMPA) released the 109th Catalog of Reference Listed Drugs for Chemical Generic Drugs, adding 30 new product specifications and supplementing information for 24 product specifications…

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

China's NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

China’s NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
NMPA Issues New Quality Management Standards for Online Medical Device Sales
NMPA

NMPA Issues New Quality Management Standards for Online Medical Device Sales

NHSA Launches Intelligent Supervision Reform Pilot in Designated Medical Institutions
NHSA (prev. SMIA)

NHSA Launches Intelligent Supervision Reform Pilot in Designated Medical Institutions

Digital-Intelligent Transformation of China's Pharmaceutical Industry: 2025-2030 Plan Unveiled
AISmart medical care; wearables; IoT

Digital-Intelligent Transformation of China’s Pharmaceutical Industry: 2025-2030 Plan Unveiled

Trump Administration Considers Tying US Drug Prices to International Benchmarks
Trump tariffs

Trump Administration Considers Tying US Drug Prices to International Benchmarks

Show More